| Characteristic |
Totale
|
Glycemic Control YES
|
Glycemic Control NO
|
|---|---|---|---|
| N = 4771 | N = 1512 | N = 3262 | |
| Sex (n, %) | |||
| F | 296 (62%) | ||
| M | 181 (38%) | ||
| Age (median, IQR) | 55 (47 - 64) | ||
| BMI (median, IQR) | 25.3 (22.1 - 29.2) | ||
| Time in treatment, months (median, IQR) | 34 (14 - 49) | ||
| Hypertension (n, %) | |||
| N | 205 (43%) | ||
| Y | 272 (57%) | ||
| Chronic kidney disease (n, %) | |||
| N | 468 (98%) | ||
| Y | 9 (1.9%) | ||
| HIV status (n, %) | |||
| HIV_NA | 453 (95%) | ||
| HIV_NO | 18 (3.8%) | ||
| HIV_YES | 6 (1.3%) | ||
| Sexe | |||
| F | 81 (54%) | 215 (66%) | |
| M | 70 (46%) | 111 (34%) | |
| age | 57 (47 - 67) | 55 (46 - 64) | |
| BMI | 25.2 (22.1 - 30.0) | 25.4 (22.0 - 28.7) | |
| Unknown | 1 | 2 | |
| T_glic_diagnosi_mesi | 28 (13 - 48) | 35 (16 - 49) | |
| Unknown | 1 | 1 | |
| Hypertension | |||
| N | 67 (44%) | 138 (42%) | |
| Y | 84 (56%) | 188 (58%) | |
| CKD | |||
| N | 147 (97%) | 321 (98%) | |
| Y | 4 (2.6%) | 5 (1.5%) | |
| hiv | |||
| HIV_NA | 141 (93%) | 312 (96%) | |
| HIV_NO | 8 (5.3%) | 10 (3.1%) | |
| HIV_YES | 2 (1.3%) | 4 (1.2%) | |
| 1 n (%) | |||
| 2 n (%); Median (Q1 - Q3) | |||